Adult women have to pay up to R$ 3,000 to get vaccinated against HPV in the private network
Many adult women in Brazil face high costs to obtain the HPV vaccine due to age limits and lack of comprehensive access in the public health system.
Positive news: HPV vaccine provides long-term protection
A new Swedish study shows that the HPV vaccine reduces the risk of cervical cancer for at least 18 years, with those vaccinated before age 17 experiencing nearly an 80% lower risk than unvaccinated women.
Hope Against Triple Negative Breast Cancer: Experimental Vaccine Shows Positive Results
An experimental mRNA vaccine shows promising outcomes in a small trial for triple-negative breast cancer patients.
Initial success of a personalized vaccine against triple-negative breast cancer, the most aggressive
A clinical trial shows promising results for a personalized vaccine targeting triple-negative breast cancer, with hopes for approval within four years.
Personalized vaccine against triple-negative breast cancer could change treatment in Mexico
A new personalized mRNA vaccine being developed in Mexico may transform treatment for triple-negative breast cancer, a particularly aggressive subtype of the disease.
Leader: Because of Trump, there might be no vaccine for cancer
The article discusses how Donald Trump's political actions in the U.S. may impede the development of a promising cancer vaccine based on mRNA technology.
Nonavalent Vaccine Against HPV Receives Indication for Head and Neck Tumors
Brazil's nonavalent HPV vaccine has been updated to include protection against oropharyngeal cancer and other head and neck tumors associated with the virus.
Anvisa approves new indication for HPV vaccine to prevent oropharyngeal, head, and neck cancers
Brazil's health regulatory agency Anvisa has approved a new indication for the HPV vaccine Gardasil 9 to prevent oropharyngeal, head, and neck cancers in individuals aged 9 to 45.
Great Expectations for Vaccine Against Advanced Lung Cancer: What the Director of St. Savvas Oncology Says
The director of St. Savvas Oncology, Alexandros Ardavani, expresses optimism regarding an mRNA therapeutic vaccine currently undergoing trials for advanced lung cancer.
HPV vaccine shows lasting protection after 12 years, study indicates
A population study in Scotland shows that the HPV vaccination has long-lasting effects, with a sustained reduction in high-grade cervical lesions among over 270,000 women monitored for up to 12 years.
Rwanda: Rwanda to Introduce Vaccine Against Six Cancers
Rwanda plans to introduce Gardasil 9, a new HPV vaccine, to enhance cancer protection and aims to eliminate cervical cancer by 2027, potentially becoming the first African nation to include it in its national immunization program.
HPV: Only three times in life for early detection?
The HPV vaccine is deemed a significant medical success, capable of preventing a majority of cervical cancer cases, and Australia aims to fully eliminate the disease by 2035 due to its effective national HPV vaccination program.
Children with brain cancer given hope through trial of personalised vaccines
A trial of personalized vaccines for children with brain cancer is set to begin in eight Australian hospitals, involving around 70 patients over four years.
"Turbo Cancer" from Vaccination? Here Are the Facts
The article discusses the unfounded claims made by anti-vaccine movements regarding the emergence of 'Turbo Cancer' as a severe side effect of vaccinations, particularly in the context of the COVID-19 pandemic.
Football tournament in Zimbabwe spreads awareness of cervical cancer
A football tournament in Zimbabwe highlighted cervical cancer awareness and promoted the HPV vaccine among 200 teenage girls from six African countries.
A vaccine to prevent colon cancer shows promising results
A preventive vaccine, Nous-209, shows promising results in initial trials with patients at a significantly higher risk of developing tumors.